HLA-G expression in human breast cancer: Implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro

Annals of Surgical Oncology

Volumn 17, Issue 5, 2010, Pages 1459-1469

  He, Xu ^a   Dong, Dan Dan ^b   Yie, Shang Mian ^a,c   Yang, Hong ^b   Cao, Mei ^a   Ye, Shang Rong ^c   Li, Ke ^b   Liu, Ji ^c   Chen, Jie ^a  

^a Sichuan Academy of Medical Sciences   (China)

^b SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c Chengdu Bioengineering Institute for Cancer Research   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; HLA G ANTIGEN; MIFEPRISTONE; PROGESTERONE; TAMOXIFEN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG EFFECT; DRUG RESPONSE; HUMAN; HUMAN TISSUE; PROGNOSIS; SURVIVAL RATE;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTRADIOL; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HORMONE ANTAGONISTS; HORMONES; HUMANS; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; MIFEPRISTONE; NEOPLASM STAGING; PROGESTERONE; PROGNOSIS; SURVIVAL RATE; T-LYMPHOCYTES, CYTOTOXIC; TAMOXIFEN; TUMOR CELLS, CULTURED;

EID: 77952091664     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0891-9     Document Type: Article

References (32)

1. J LeMaoult N Rouas-Freiss ED Carosella 2005 Immuno-tolerogenic functions of HLA-G: relevance in transplantation and oncology Autoimmun Rev. 4 503 509 10.1016/j.autrev.2005.04.006 1:CAS:528:DC%2BD2MXht1KktLfM 16214086 (Pubitemid 41415760)
2. ED Carosella P Moreau J Lemaoult N Rouas-Freiss 2008 HLA-G: From biology to clinical benefits Trends Immunol. 29 125 132 10.1016/j.it.2007.11.005 1:CAS:528:DC%2BD1cXivVeis7Y%3D 18249584
3. SR Ye H Yang K Li DD Dong XM Lin SM Yie 2007 Human leukocyte antigen G expression: As a significant prognostic indicator for patients with colorectal cancer Mod Pathol. 20 375 383 10.1038/modpathol.3800751 1:CAS:528: DC%2BD2sXitlSju74%3D 17277760 (Pubitemid 46348337)
4. SM Yie H Yang SR Ye K Li DD Dong XM Lin 2007 Expression of HLA-G is associated with prognosis in esophageal squamous cell carcinoma Am J Clin Pathol. 128 1002 1009 10.1309/JNCW1QLDFB6AM9WE 18024326 (Pubitemid 47516690)
5. SM Yie H Yang SR Ye K Li DD Dong XM Lin 2007 Expression of human leucocyte antigen G (HLA-G) is associated with prognosis in non-small cell lung cancer Lung Cancer. 58 267 274 10.1016/j.lungcan.2007.06.011 17673327 (Pubitemid 47516690)
6. SM Yie H Yang SR Ye K Li DD Dong XM Lin 2007 Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma Ann Surg Oncol. 14 2721 2729 17564748 (Pubitemid 47460633)
7. H Nückel V Rebmann J Dürig U Dührsen H Grosse-Wilde 2005 HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia Blood. 105 1694 1698 10.1182/blood-2004-08-3335 15466928 (Pubitemid 40223692)
8. S Lefebvre M Antoine S Uzan M McMaster J Dausset ED Carosella, et al. 2002 Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer J Pathol. 196 266 274 10.1002/path.1039 1:CAS:528:DC%2BD38XisVWlt7k%3D 11857488 (Pubitemid 34189414)
9. G Singer V Rebmann YC Chen HT Liu SZ Ali J Reinsberg, et al. 2003 HLA-G is a potential tumor marker in malignant ascites Clin Cancer Res. 9 4460 4464 1:CAS:528:DC%2BD3sXotVShtr4%3D 14555519 (Pubitemid 37248404)
10. L Kleinberg VA Flørenes M Skrede HP Dong SR Nielsen MT McMaster, et al. 2006 Expression of HLA-G in malignant mesothelioma and clinically aggressive breast carcinoma Virchows Arch. 449 31 39 10.1007/s00428-005-0144-7 1:CAS:528:DC%2BD28Xmtlais7o%3D 16541284 (Pubitemid 43988363)
11. IeM Shih 2007 Application of human leukocyte antigen-G expression in the diagnosis of human cancer Hum Immunol. 68 272 276 10.1016/j.humimm.2007.01.010 1:CAS:528:DC%2BD2sXjslShsrs%3D 17400063 (Pubitemid 46497525)
12. JR Benson V Pitsinis 2003 Update on clinical role of tamoxifen Curr Opin Obstet Gynecol. 15 13 23 10.1097/00001703-200302000-00003 12544497 (Pubitemid 36143488)
13. JG Klijn B Setyono-Han JA Foekens 2000 Progesterone antagonists and progesterone receptor modulators in the treatment of breast cancer Steroids. 65 825 830 10.1016/S0039-128X(00)00195-1 1:CAS:528:DC%2BD3cXosFCisLk%3D 11108894
14. M Thomas JD Monet 1992 Combined effects of RU486 and tamoxifen on the growth and cell cycle phases of the MCF-7 cell line J Clin Endocrinol Metab. 75 865 870 10.1210/jc.75.3.865 1:CAS:528:DyaK38XmtVGnsr4%3D 1517379
15. VT Gaddy JT Barrett JN Delk AM Kallab AG Porter PV Schoenlein 2004 Mifepristone induces growth arrest, caspase activation, and apoptosis of estrogen receptor-expressing, antiestrogen-resistant breast cancer cells Clin Cancer Res. 10 5215 5225 10.1158/1078-0432.CCR-03-0637 1:CAS:528: DC%2BD2cXmtlSiurk%3D 15297425 (Pubitemid 39099796)
16. SM Yie LH Li GM Li R Xiao CL Librach 2006 Progesterone enhances HLA-G gene expression in JEG-3 choriocarcinoma cells and human cytotrophoblasts in vitro Hum Reprod. 21 46 51 10.1093/humrep/dei305 1:CAS:528:DC%2BD2MXht1OqtL7O 16210391 (Pubitemid 41794290)
17. R Sheshgiri V Rao LC Tumiati R Xiao JL Prodger M Badiwala, et al. 2008 Progesterone induces human leukocyte antigen-g expression in vascular endothelial and smooth muscle cells Circulation 118 14 Suppl S58 64 10.1161/CIRCULATIONAHA.107.757781 1:CAS:528:DC%2BD1cXhtFKjurnP 18824770
18. C Pangault L Amiot S Caulet-Maugendre F Brasseur F Burtin V Guilloux, et al. 1999 HLA-G protein expression is not induced during malignant transformation Tissue Antigens. 53 335 346 10.1034/j.1399-0039.1999.530403.x 1:CAS:528:DyaK1MXjtVGhs7k%3D 10323337
19. Fleming I, Cooper J, Henson D, Hutter R, Kennedy B, Murphy G, et al. (editors) American Joint Committee on cancer staging manual. 5th ed. Philadephia: JB Lippincott;1997.
20. S Yie L Li Y Li C Librach, et al. 2004 HLA-G protein concentrations in maternal serum and placental tissue are decreased in preeclampsia Am J Obstet Gynecol. 191 525 529 10.1016/j.ajog.2004.01.033 1:CAS:528:DC%2BD2cXntlGntbw%3D 15343231 (Pubitemid 39178708)
21. K Kapasi SE Albert SM Yie N Zavazava CL Librach 2000 HLA-G has a concentration-dependent effect on the generation of an allo-CTL response Immunology. 101 191 200 10.1046/j.1365-2567.2000.00109.x 1:CAS:528: DC%2BD3cXns1aqt7g%3D 11012772
22. J Alexander T Watanable TT Wu A Rashid S Li SR Hamilton 2001 Histopathological identification of colon cancer with microsatellite instability Am J Pathol. 158 527 535 1:STN:280:DC%2BD3M7psVerug%3D%3D 11159189 (Pubitemid 32158613)
23. KJ Livak TD Schmittgen 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCt method Methods. 25 402 408 10.1006/meth.2001.1262 1:CAS:528:DC%2BD38XhtFelt7s%3D 11846609 (Pubitemid 34164012)
24. S Ugurel V Rebmann S Ferrone W Tilgen H Grosse-Wilde U Reinhold 2001 Soluble human leukocyte antigen-G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy Cancer. 92 369 376 10.1002/1097-0142(20010715)92:2<369::AID-CNCR1332>3.0.CO;2-U 1:STN:280:DC%2BD3Mvhs1yqug%3D%3D 11466692 (Pubitemid 32664444)
25. X Leleu G Le Friec T Facon L Amiot R Fauchet B Hannache, et al. 2005 Total soluble HLA class I and soluble HLA-G in multiple myeloma and monoclonal gammopathy of undetermined significance Clin Cancer Res. 11 7297 7303 10.1158/1078-0432.CCR-05-0456 1:CAS:528:DC%2BD2MXhtFartb3L 16243800 (Pubitemid 41507687)
26. F Gros Y Sebti S de Guibert B Branger M Bernard R Fauchet, et al. 2006 Soluble HLA-G molecules increase during acute leukemia, especially in subtypes affecting monocytic and lymphoid lineages Neoplasia. 8 223 230 10.1593/neo.05703 1:CAS:528:DC%2BD28XovVKlurc%3D 16611416 (Pubitemid 43671238)
27. Y Sebti A Le Maux F Gros S De Guibert C Pangault N Rouas-Freiss, et al. 2007 Expression of functional soluble human leucocyte antigen-G molecules in lymphoproliferative disorders Br J Haematol. 138 202 212 10.1111/j.1365-2141. 2007.06647.x 1:CAS:528:DC%2BD2sXptFGgtbY%3D 17593027 (Pubitemid 46976330)
28. F Morandi I Levreri P Bocca B Galleni L Raffaghello S Ferrone, et al. 2007 Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-G release Cancer Res. 67 6433 6441 10.1158/0008-5472.CAN-06-4588 1:CAS:528:DC%2BD2sXnsVyqtbo%3D 17616704 (Pubitemid 47037528)
29. JI MacGregor VC Jordan 1998 Basic guide to the mechanisms of antiestrogen action Pharmacol Rev. 50 151 196 1:CAS:528:DyaK1cXksFClsbY%3D 9647865
30. LJ Schild-Hay TA Leil RL Divi OA Olivero A Weston MC Poirier 2009 Tamoxifen induces expression of immune response-related genes in cultured normal human mammary epithelial cells Cancer Res. 69 1150 1155 10.1158/0008-5472.CAN- 08-2806 1:CAS:528:DC%2BD1MXhtFOlurc%3D 19155303
31. W Regelson 1992 RU486: How abortion politics have impacted on a potentially useful drug of broad medical application Perspect Biol Med. 35 330 338 1:STN:280:DyaK38zms1arsQ%3D%3D 1501996
32. S Slavin 2005 Allogeneic cell-mediated immunotherapy at the stage of minimal residual disease following high-dose chemotherapy supported by autologous stem cell transplantation Acta Haematol. 114 214 220 10.1159/000088412 16269861 (Pubitemid 41567004)